首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
PHASE-II STUDY OF IFOSFAMIDE-ETOPOSIDE-MESNA IN ADULTS WITH ADVANCED NONOSSEOUS SARCOMAS
被引:21
|
作者
:
EDMONSON, JH
论文数:
0
引用数:
0
h-index:
0
EDMONSON, JH
BUCKNER, JC
论文数:
0
引用数:
0
h-index:
0
BUCKNER, JC
LONG, HJ
论文数:
0
引用数:
0
h-index:
0
LONG, HJ
LOPRINZI, CL
论文数:
0
引用数:
0
h-index:
0
LOPRINZI, CL
SCHAID, DJ
论文数:
0
引用数:
0
h-index:
0
SCHAID, DJ
机构
:
来源
:
JOURNAL OF THE NATIONAL CANCER INSTITUTE
|
1989年
/ 81卷
/ 11期
关键词
:
D O I
:
10.1093/jnci/81.11.863
中图分类号
:
R73 [肿瘤学];
学科分类号
:
100214 ;
摘要
:
引用
收藏
页码:863 / 866
页数:4
相关论文
共 50 条
[31]
ETOPOSIDE AS A SINGLE AGENT IN RELAPSED ADVANCED LYMPHOMAS - A PHASE-II STUDY
TAYLOR, RE
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES,SUTTON SM2 5PX,SURREY,ENGLAND
TAYLOR, RE
MCELWAIN, TJ
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES,SUTTON SM2 5PX,SURREY,ENGLAND
MCELWAIN, TJ
BARRETT, A
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES,SUTTON SM2 5PX,SURREY,ENGLAND
BARRETT, A
PECKHAM, MJ
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES,SUTTON SM2 5PX,SURREY,ENGLAND
PECKHAM, MJ
CANCER CHEMOTHERAPY AND PHARMACOLOGY,
1982,
7
(2-3)
: 175
-
177
[32]
IFOSFAMIDE WITH MESNA UROPROTECTION AND ETOPOSIDE - AN EFFECTIVE REGIMEN IN THE TREATMENT OF RECURRENT SARCOMAS AND OTHER TUMORS OF CHILDREN AND YOUNG-ADULTS
MISER, JS
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,PEDIAT BRANCH,BETHESDA,MD 20205
MISER, JS
KINSELLA, TJ
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,PEDIAT BRANCH,BETHESDA,MD 20205
KINSELLA, TJ
TRICHE, TJ
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,PEDIAT BRANCH,BETHESDA,MD 20205
TRICHE, TJ
TSOKOS, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,PEDIAT BRANCH,BETHESDA,MD 20205
TSOKOS, M
JAROSINSKI, P
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,PEDIAT BRANCH,BETHESDA,MD 20205
JAROSINSKI, P
FORQUER, R
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,PEDIAT BRANCH,BETHESDA,MD 20205
FORQUER, R
WESLEY, R
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,PEDIAT BRANCH,BETHESDA,MD 20205
WESLEY, R
MAGRATH, I
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,PEDIAT BRANCH,BETHESDA,MD 20205
MAGRATH, I
JOURNAL OF CLINICAL ONCOLOGY,
1987,
5
(08)
: 1191
-
1198
[33]
CARBOPLATIN AND ETOPOSIDE IN ADVANCED COLORECTAL-CARCINOMA - A PHASE-II STUDY
JEREMIC, B
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV HOSP KRAGUJEVAC, DEPT ONCOL, KRAGUJEVAC, YUGOSLAVIA
JEREMIC, B
ACIMOVIC, L
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV HOSP KRAGUJEVAC, DEPT ONCOL, KRAGUJEVAC, YUGOSLAVIA
ACIMOVIC, L
MIJATOVIC, L
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV HOSP KRAGUJEVAC, DEPT ONCOL, KRAGUJEVAC, YUGOSLAVIA
MIJATOVIC, L
CANCER,
1993,
71
(09)
: 2706
-
2708
[34]
PHASE-II STUDY OF AZOTOMYCIN IN SARCOMAS
CHANG, P
论文数:
0
引用数:
0
h-index:
0
CHANG, P
WIERNIK, PH
论文数:
0
引用数:
0
h-index:
0
WIERNIK, PH
CANCER TREATMENT REPORTS,
1977,
61
(09):
: 1719
-
1720
[35]
PHASE-II STUDY OF A COMBINATION OF MITOMYCIN, DOXORUBICIN AND CISPLATIN IN ADVANCED SARCOMAS
EDMONSON, JH
论文数:
0
引用数:
0
h-index:
0
机构:
CANC CTR STAT UNIT,ROCHESTER,MN
CANC CTR STAT UNIT,ROCHESTER,MN
EDMONSON, JH
LONG, HJ
论文数:
0
引用数:
0
h-index:
0
机构:
CANC CTR STAT UNIT,ROCHESTER,MN
CANC CTR STAT UNIT,ROCHESTER,MN
LONG, HJ
RICHARDSON, RL
论文数:
0
引用数:
0
h-index:
0
机构:
CANC CTR STAT UNIT,ROCHESTER,MN
CANC CTR STAT UNIT,ROCHESTER,MN
RICHARDSON, RL
CREAGAN, ET
论文数:
0
引用数:
0
h-index:
0
机构:
CANC CTR STAT UNIT,ROCHESTER,MN
CANC CTR STAT UNIT,ROCHESTER,MN
CREAGAN, ET
GREEN, SJ
论文数:
0
引用数:
0
h-index:
0
机构:
CANC CTR STAT UNIT,ROCHESTER,MN
CANC CTR STAT UNIT,ROCHESTER,MN
GREEN, SJ
CANCER CHEMOTHERAPY AND PHARMACOLOGY,
1985,
15
(02)
: 181
-
182
[36]
High-dose ifosfamide by infusion with Mesna in advanced refractory sarcomas
Gullu, I
论文数:
0
引用数:
0
h-index:
0
机构:
HACETTEPE UNIV,INST ONCOL,ANKARA,TURKEY
HACETTEPE UNIV,INST ONCOL,ANKARA,TURKEY
Gullu, I
Yalcin, S
论文数:
0
引用数:
0
h-index:
0
机构:
HACETTEPE UNIV,INST ONCOL,ANKARA,TURKEY
HACETTEPE UNIV,INST ONCOL,ANKARA,TURKEY
Yalcin, S
Tekuzman, G
论文数:
0
引用数:
0
h-index:
0
机构:
HACETTEPE UNIV,INST ONCOL,ANKARA,TURKEY
HACETTEPE UNIV,INST ONCOL,ANKARA,TURKEY
Tekuzman, G
Barista, I
论文数:
0
引用数:
0
h-index:
0
机构:
HACETTEPE UNIV,INST ONCOL,ANKARA,TURKEY
HACETTEPE UNIV,INST ONCOL,ANKARA,TURKEY
Barista, I
Alkis, N
论文数:
0
引用数:
0
h-index:
0
机构:
HACETTEPE UNIV,INST ONCOL,ANKARA,TURKEY
HACETTEPE UNIV,INST ONCOL,ANKARA,TURKEY
Alkis, N
Celik, I
论文数:
0
引用数:
0
h-index:
0
机构:
HACETTEPE UNIV,INST ONCOL,ANKARA,TURKEY
HACETTEPE UNIV,INST ONCOL,ANKARA,TURKEY
Celik, I
Zengin, N
论文数:
0
引用数:
0
h-index:
0
机构:
HACETTEPE UNIV,INST ONCOL,ANKARA,TURKEY
HACETTEPE UNIV,INST ONCOL,ANKARA,TURKEY
Zengin, N
Guler, N
论文数:
0
引用数:
0
h-index:
0
机构:
HACETTEPE UNIV,INST ONCOL,ANKARA,TURKEY
HACETTEPE UNIV,INST ONCOL,ANKARA,TURKEY
Guler, N
Kars, A
论文数:
0
引用数:
0
h-index:
0
机构:
HACETTEPE UNIV,INST ONCOL,ANKARA,TURKEY
HACETTEPE UNIV,INST ONCOL,ANKARA,TURKEY
Kars, A
Baltali, E
论文数:
0
引用数:
0
h-index:
0
机构:
HACETTEPE UNIV,INST ONCOL,ANKARA,TURKEY
HACETTEPE UNIV,INST ONCOL,ANKARA,TURKEY
Baltali, E
Kansu, E
论文数:
0
引用数:
0
h-index:
0
机构:
HACETTEPE UNIV,INST ONCOL,ANKARA,TURKEY
HACETTEPE UNIV,INST ONCOL,ANKARA,TURKEY
Kansu, E
Firat, D
论文数:
0
引用数:
0
h-index:
0
机构:
HACETTEPE UNIV,INST ONCOL,ANKARA,TURKEY
HACETTEPE UNIV,INST ONCOL,ANKARA,TURKEY
Firat, D
CANCER INVESTIGATION,
1996,
14
(03)
: 239
-
242
[37]
A PHASE-II EVALUATION OF IFOSFAMIDE AND MESNA IN UNRESECTABLE DIFFUSE MALIGNANT MESOTHELIOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY
ZIDAR, BL
论文数:
0
引用数:
0
h-index:
0
机构:
ALLEGHENY HLTH EDUC & RES FDN,PITTSBURGH,PA
ZIDAR, BL
METCH, B
论文数:
0
引用数:
0
h-index:
0
机构:
ALLEGHENY HLTH EDUC & RES FDN,PITTSBURGH,PA
METCH, B
BALCERZAK, SP
论文数:
0
引用数:
0
h-index:
0
机构:
ALLEGHENY HLTH EDUC & RES FDN,PITTSBURGH,PA
BALCERZAK, SP
PIERCE, HI
论文数:
0
引用数:
0
h-index:
0
机构:
ALLEGHENY HLTH EDUC & RES FDN,PITTSBURGH,PA
PIERCE, HI
MILITELLO, L
论文数:
0
引用数:
0
h-index:
0
机构:
ALLEGHENY HLTH EDUC & RES FDN,PITTSBURGH,PA
MILITELLO, L
KEPPEN, MD
论文数:
0
引用数:
0
h-index:
0
机构:
ALLEGHENY HLTH EDUC & RES FDN,PITTSBURGH,PA
KEPPEN, MD
BERENBERG, JL
论文数:
0
引用数:
0
h-index:
0
机构:
ALLEGHENY HLTH EDUC & RES FDN,PITTSBURGH,PA
BERENBERG, JL
CANCER,
1992,
70
(10)
: 2547
-
2551
[38]
PHASE-II STUDY OF IFOSFAMIDE (HOLOXAN) IN HEPATOMA
THONGPRASERT, S
论文数:
0
引用数:
0
h-index:
0
THONGPRASERT, S
KLUNKLIN, K
论文数:
0
引用数:
0
h-index:
0
KLUNKLIN, K
PHORNPHUTKUL, K
论文数:
0
引用数:
0
h-index:
0
PHORNPHUTKUL, K
PRISONTARANGKUL, OA
论文数:
0
引用数:
0
h-index:
0
PRISONTARANGKUL, OA
CHAIMONGKOL, B
论文数:
0
引用数:
0
h-index:
0
CHAIMONGKOL, B
SIVASOMBOON, B
论文数:
0
引用数:
0
h-index:
0
SIVASOMBOON, B
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY,
1988,
24
(11):
: 1795
-
1796
[39]
PHASE-II STUDY OF IFOSFAMIDE COMBINED WITH MESNA UROPROTECTION IN ADVANCED NON-SMALL-CELL LUNG-CARCINOMA AND OTHER SOLID TUMORS
NOBILE, MT
论文数:
0
引用数:
0
h-index:
0
机构:
IST NAZL RIC CANCRO,DIV ONCOL MED,VIALE BENEDETTO XV 10,I-16132 GENOVA,ITALY
NOBILE, MT
ROSSO, R
论文数:
0
引用数:
0
h-index:
0
机构:
IST NAZL RIC CANCRO,DIV ONCOL MED,VIALE BENEDETTO XV 10,I-16132 GENOVA,ITALY
ROSSO, R
BREMA, F
论文数:
0
引用数:
0
h-index:
0
机构:
IST NAZL RIC CANCRO,DIV ONCOL MED,VIALE BENEDETTO XV 10,I-16132 GENOVA,ITALY
BREMA, F
CINQUEGRANA, A
论文数:
0
引用数:
0
h-index:
0
机构:
IST NAZL RIC CANCRO,DIV ONCOL MED,VIALE BENEDETTO XV 10,I-16132 GENOVA,ITALY
CINQUEGRANA, A
SANTI, L
论文数:
0
引用数:
0
h-index:
0
机构:
IST NAZL RIC CANCRO,DIV ONCOL MED,VIALE BENEDETTO XV 10,I-16132 GENOVA,ITALY
SANTI, L
TUMORI,
1984,
70
(05)
: 433
-
437
[40]
PHASE-II STUDY OF CARBOPLATIN IFOSFAMIDE IN UNTREATED ADVANCED CERVICAL-CANCER
KUHNLE, H
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV FREIBURG,FRAUENKLIN,HUGSTETTER STR,W-7800 FREIBURG,GERMANY
KUHNLE, H
MEERPOHL, HG
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV FREIBURG,FRAUENKLIN,HUGSTETTER STR,W-7800 FREIBURG,GERMANY
MEERPOHL, HG
EIERMANN, W
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV FREIBURG,FRAUENKLIN,HUGSTETTER STR,W-7800 FREIBURG,GERMANY
EIERMANN, W
ROBEN, S
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV FREIBURG,FRAUENKLIN,HUGSTETTER STR,W-7800 FREIBURG,GERMANY
ROBEN, S
LENAZ, L
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV FREIBURG,FRAUENKLIN,HUGSTETTER STR,W-7800 FREIBURG,GERMANY
LENAZ, L
ACHTERRATH, W
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV FREIBURG,FRAUENKLIN,HUGSTETTER STR,W-7800 FREIBURG,GERMANY
ACHTERRATH, W
CANCER CHEMOTHERAPY AND PHARMACOLOGY,
1990,
26
: S33
-
S35
←
1
2
3
4
5
→